ICU Medical Inc (ICUI)
Return on equity (ROE)
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | -29,655 | -74,286 | 103,135 | 86,870 | 101,035 |
Total stockholders’ equity | US$ in thousands | 2,123,410 | 2,089,930 | 1,616,030 | 1,502,260 | 1,377,240 |
ROE | -1.40% | -3.55% | 6.38% | 5.78% | 7.34% |
December 31, 2023 calculation
ROE = Net income ÷ Total stockholders’ equity
= $-29,655K ÷ $2,123,410K
= -1.40%
ICU Medical, Inc.'s return on equity (ROE) has experienced fluctuations in the past five years. The ROE was negative in both 2022 and 2023, indicating that the company's net income was insufficient to generate a positive return for shareholders. This could be a concerning trend, as a negative ROE suggests that the company is not effectively utilizing shareholders' equity to generate profits.
In contrast, the ROE was positive in 2021, 2020, and 2019, demonstrating that the company was able to generate returns for its shareholders during those years. The ROE peaked in 2019 at 7.34%, suggesting that the company was particularly efficient in utilizing its equity to generate profits that year.
Overall, it is important for ICU Medical, Inc. to closely monitor its ROE and work towards improving profitability and efficiency in order to provide sustainable returns for its shareholders in the future.
Peer comparison
Dec 31, 2023